Swedish Orphan Biovitrum, Syngenta, Rare Disease Therapeutics sales and marketing update

On Dec. 20, 2013, Swedish Orphan said it terminated a distribution deal with Rare Disease Therapeutics for Orfadin nitisinone in the U.S., Canada and Latin America. Distribution rights will transfer ...